Peptide Vials (Tirzepatide, 15 mg each): 8 weeks (2.55 mg/wk): ~30 mg total 2 vials 12 weeks (2.57.5 mg/wk): ~60 mg total 4 vials 16 weeks (2.510 mg/wk): ~100 mg total 7 vials Insulin Syringes (U100, 1 mL): 8 weeks: 8 syringes (1/week) 12 weeks: 12 syringes (1/week) 16 weeks: 20 syringes (1/week wks 112, 2/week wks 1316) Bacteriostatic Water (10 mL bottles): Use 2.0 mL per vial for reconstitution
Lyophilisation, or freeze-drying, is a process used to preserve the peptide, resulting in a solid puck of lyophilised powder that is reactivated through reconstitution
The same cellular mechanisms that help reduce stubborn fatnamely, the inhibition of the NNMT enzyme and the resulting preservation of NAD+also play a fundamental role in how our bodies age and manage energy system-wide
The inclusion in compounded tirzepatide provides a small but consistent weekly dose
Sahdev A
While BPC-157 appears safe based on available evidence, the lack of long-term human studies means unknown risks could exist
